Carl Icahn
Carl Icahn's Portfolio
| Ticker | # of Shares | Price | Value | |
|---|---|---|---|---|
| BIIB | 17,511,304 | $59.63 | $1,044,199,058 | |
| APC | 14,401,628 | $69.99 | $1,007,969,944 | |
| MOT | 137,741,443 | $7.18 | $988,983,561 | |
| YHOO | 55,039,056 | $16.44 | $904,842,081 | |
| IMCL | 11,669,544 | $69.99 | $816,751,385 | |
| LEA | 9,595,954 | $77.74 | $745,989,464 | |
| TWX | 12,933,159 | $31.24 | $404,031,888 | |
| TWC | 4,711,128 | $48.76 | $229,714,602 | |
| AMLN | 6,787,649 | $22.49 | $152,654,227 | |
| WMB | 3,918,959 | $22.53 | $88,294,147 | |
| View Additional Portfolio Information » | ||||
Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.
Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.
Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.
In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.
In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.
Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.
In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.
Summary of Carl Icahn's Icahn Capital LP 13F for the quarter ended December 31, 2007, compared to the quarter ended Sept 30, 2007.
New Stakes:
Amicus Therapeutics, Inc. (Nasdaq: FOLD) new 201,940 share stake
Perry Ellis International Inc. (Nasdaq: PERY) new 206,025 share stake
Forestar Real Estate Group Inc (NYSE: FOR) 1,149,495 share stake (spin-off from Temple-Inland, which Icahn owned a stake in prior.
Guaranty Financial Group (NYSE ...
